Nuclear mechanisms underpinning mitochondrial vulnerability in different cell-types
Year of award: 2023
Grantholders
Prof Patrick Chinnery
University of Cambridge, United Kingdom
Prof Rita Horvath
University of Cambridge, United Kingdom
Dr Jelle Van Den Ameele
University of Cambridge, United Kingdom
Project summary
Mitochondria play a central role in the homeostasis of nucleated cells, but mitochondrial insults preferentially affect some cell-types and not others. The reasons for this are not clear. Our over-arching aim is to define the principal mechanisms underpinning cell-type-specific mitochondrial vulnerability. We will take a reductionist approach, focussed on genetic disorders of intra-mitochondrial translation caused by mutations affecting mitochondrial DNA (mtDNA) transfer RNA genes and their corresponding nuclear-encoded mitochondrial aminoacyl tRNA synthetases (mt-aaRS). Our five specific inter-related aims are: Aim-1: To discover the key nuclear genes regulating mtDNA-heteroplasmy and mtDNA-levels in different cell types using single-cell functional genomic screens. Aim-2: To define cell-type-specific nuclear transcriptional signatures that modulate mitochondrial function throughout life in health and disease. Aim-3: To determine the role of canonical and non-canonical functions of mt-aaRS in cell-type-specific vulnerability. Aim-4: To characterise cell-type-specific downstream consequences of disrupting mitochondrial protein synthesis, focussing on the integrated stress response (ISR). Aim-5: To discover new mtDNA-nuclear DNA interactions in undiagnosed patients with tissue-specific mitochondrial disorders using genomics. Given emerging evidence that mitochondria contribute to many common late-onset diseases, our findings will have broader relevance for understanding tissue and cell vulnerability in many human disorders, potentially identifying new cell-type-specific therapeutic targets.